They may attenuate the pathogenicity of BRCA2 variants in FA-D1 patients, but also function in the presence of a BRCA2 wild-type allele in BRCA2-PV carriers and may even have some effect in non-FA tissues. Here, BRCA2 is linked to Friedreich ataxia.